... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
Medicine Products:(Date:5/20/2008)...less than 5% trust magazines or advertising for,tr...-USNewswire/ -- The Physicians Coalition,for Injec...nd the health and,beauty community RealSelf.com ( ...of a joint survey reporting that 40% of consumers ...y 58% of consumers feel FDA approval,of an injecta...
(Date:5/20/2008)...ay 20 /PRNewswire-FirstCall/ -- Mercury Computer,S...of specialized,high-performance computing solutio...g applications, announced that management will pre...sday, May 29, 2008 at the Cowen and,Company 20/20 ...e will be,held at the New York Palace Hotel, in Ne...
(Date:5/20/2008)...ped approaches to designing a preventive HIV vacci...us Diseases (NIAID), part of the National Institut... the study of B cells, immune cells that can produ... The $15.6 million, five-year program will strengt...ccine research through a network of 10 research te...
(Date:5/20/2008)...ay 20 /PRNewswire/ -- New research that delivers,i...d competitive,intelligence data gathering for the ...ice Database, an online research repository manage...LLC., To review sample key findings and key metri...ks to each study at this address:, http://www3.bes...
Breaking Medicine News(10 mins):Health News:New Survey Suggests That Consumers Are Naive to the Risk of Botox Parties and the Importance of FDA Approval for Cosmetic Injectables 2Health News:New Survey Suggests That Consumers Are Naive to the Risk of Botox Parties and the Importance of FDA Approval for Cosmetic Injectables 3Health News:New Survey Suggests That Consumers Are Naive to the Risk of Botox Parties and the Importance of FDA Approval for Cosmetic Injectables 4Health News:Mercury Computer Systems to Present at the Cowen and Company 20/20 Technology-Media-Telecom Conference on May 29, 2008 2Health News:NIAID to advance B-cell approach to HIV vaccines 2Health News:NIAID to advance B-cell approach to HIV vaccines 3Health News:Best Practice Database Adds Research on Merger Integration and Competitive Intelligence 2(Date:5/20/2008)...Survival Could be Extended if Patients Receive the...y ChemoFx, CHICAGO, May 20 /- Precis...moFx(R) Assay, a cell-based test that examines the... chemotherapies,correlates with significantly lon... ovarian cancer. Patients who received a treatment...
(Date:5/20/2008)...Newswire-FirstCall/ -- Stereotaxis, Inc. (Nasdaq:,... of its Niobe(R) Magnetic,Navigation System and Od...om key opinion leaders in electrophysiology at Hea...nual Scientific Sessions, which concluded on,Satur..., Dr. Xu Chen of the Rigshospitalet,-- Copenhagen ...
(Date:5/19/2008)...Newswire/ -- DDW 2008 Annual Meeting -- Ethicon,En...ts pivotal trial,demonstrated physician/nurse team... over sedation with propofol in patients undergoin...al cancer (colonoscopy), and disorders of,the uppe... will be,presented Tuesday at Digestive Disease We...
(Date:5/19/2008)...resented at the 2008 Annual European Congress of, ...nst Rheumatism (EULAR) -, - Initiation of Phase 1... 2008 -, SAN DIEGO...es, Inc.,(Nasdaq: RDEA ) today announced the iden...he treatment of patients with gout, RDEA594. Gout ...
Breaking Medicine Technology:Data Published at ASCO Find Correlation Between ChemoFx(R) Assay and Significantly Improved Overall Survival in Patients With Ovarian Cancer 2Data Published at ASCO Find Correlation Between ChemoFx(R) Assay and Significantly Improved Overall Survival in Patients With Ovarian Cancer 3Stereotaxis Market Leadership Reinforced in Core Curriculum and Symposium Presentations at Heart Rhythm 2008 2Stereotaxis Market Leadership Reinforced in Core Curriculum and Symposium Presentations at Heart Rhythm 2008 3Stereotaxis Market Leadership Reinforced in Core Curriculum and Symposium Presentations at Heart Rhythm 2008 4Pivotal Study Shows Physician/Nurse Teams Using SEDASYS(TM) System Reduced Risk of Over Sedation With Propofol 2Pivotal Study Shows Physician/Nurse Teams Using SEDASYS(TM) System Reduced Risk of Over Sedation With Propofol 3Pivotal Study Shows Physician/Nurse Teams Using SEDASYS(TM) System Reduced Risk of Over Sedation With Propofol 4Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594 2Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594 3Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594 4Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594 5ActivBiotics Proposes Development Strategy for Its Novel Rifamycin Antibiotics 1423 1ActivBiotics Proposes Development Strategy for Its Novel Rifamycin Antibiotics 1423 2Harris Corporation Demonstrates Digital Signage 28TM 29 Solutions for Dynamic Rapid Communications within Healthcare Enterprises 12578 1Harris Corporation Demonstrates Digital Signage 28TM 29 Solutions for Dynamic Rapid Communications within Healthcare Enterprises 12578 2Harris Corporation Demonstrates Digital Signage 28TM 29 Solutions for Dynamic Rapid Communications within Healthcare Enterprises 12578 3LCA Vision Announces the Opening of its 74th LasikPlus Vision Center in Des Moines Iowa 12574 1LCA Vision Announces the Opening of its 74th LasikPlus Vision Center in Des Moines Iowa 12574 2Cardiac Science Corporation Selects Colubris Networks Wireless Solution for its Portable Electrocardiograph 12570 1Cardiac Science Corporation Selects Colubris Networks Wireless Solution for its Portable Electrocardiograph 12570 2Cardiac Science Corporation Selects Colubris Networks Wireless Solution for its Portable Electrocardiograph 12570 3...ond Multinational Phase III Study Provides Further... Inhibition in the Treatment,of Rheumatoid Arthrit...ed today that,Toward (1), the second multinational...ly reached its primary endpoint and,showed that a ...a,in combination with traditional disease modifyin...
...dy Shows Safety and Pharmacokinetics Similar to IV...., June 06, 2007 /PRNewswire-FirstCall/ --,Genta I...ry,clinical results that show the Company,s lead a...injection, can be safely,administered by intermitt...ef intravenous (IV) infusion. These regimens may,e...
Other Medicine Technology:New Data Confirms Significant Improvement of Disease Signs and,Symptoms in Patients with Rheumatoid Arthritis 2New Data Confirms Significant Improvement of Disease Signs and,Symptoms in Patients with Rheumatoid Arthritis 3New Data Confirms Significant Improvement of Disease Signs and,Symptoms in Patients with Rheumatoid Arthritis 4Genta Announces Results of Phase 1 Study Using Genasense,Administered by Intermittent Subcutaneous Injection 2Genta Announces Results of Phase 1 Study Using Genasense,Administered by Intermittent Subcutaneous Injection 3Genta Announces Results of Phase 1 Study Using Genasense,Administered by Intermittent Subcutaneous Injection 4